Skip to main content
Erschienen in: European Journal of Applied Physiology 9/2013

01.09.2013 | Original Article

No effect of menstrual cycle phase on glucose and glucoregulatory endocrine responses to prolonged exercise

verfasst von: Robert R. Kraemer, Michelle Francois, Nancy Dardis Webb, Jennifer R. Worley, Sharon N. Rogers, Reid L. Norman, Urvi Shah, V. Daniel Castracane

Erschienen in: European Journal of Applied Physiology | Ausgabe 9/2013

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Prolonged exercise requires increased utilization of blood glucose and adjustment of glucoregulatory hormones. Estrogen can reduce hepatic gluconeogenesis which could affect insulin concentrations. Amylin is co-secreted with insulin and controls influx of glucose into the blood.

Purpose

To determine the effect of menstrual cycle stage on glucose, leptin, and pancreatic hormone responses to prolonged (90 min) exercise.

Methods

Five healthy, eumenorrheic women (24.6 ± 5.1 years; 67.4 ± 1 kg) were monitored for 3 months to determine menstrual cycle length. Subjects completed a preliminary session to determine exercise workloads and, in a fasted condition, completed two randomized 90-min treadmill exercise trials at 60 % VO2max during the early follicular (EFX) and mid-luteal phase (MLX) of their menstrual cycle. Blood samples were analyzed for glucose, insulin, C-peptide, amylin, glucagon, leptin, and cortisol concentrations at rest (−30 and 0 min), during exercise (18, 36, 54, 72, and 90 min) and after 20 min of recovery.

Results

No changes in amylin, leptin, or cortisol occurred for EFX and MLX trials. A significant (p < 0.05) time effect occurred for glucose, insulin, and glucagon with reduced insulin across the exercise trial and increases in glucose and glucagon later in the trial, but there were no differences between the EFX and MLX trials.

Conclusions

Menstrual cycle stage does not affect glucose, insulin, C-peptide, amylin, glucagon, cortisol, and leptin responses to prolonged exercise; however, the exercise reduces insulin and increases glucose and glucagon concentrations. This is the first study to determine acute effects of exercise on amylin and other glucoregulatory hormone responses in women.
Literatur
Zurück zum Zitat Bonen A, Haynes FW, Graham TE (1991) Substrate and hormonal responses to exercise in women using oral contraceptives. J Appl Physiol 70(5):1917–1927PubMed Bonen A, Haynes FW, Graham TE (1991) Substrate and hormonal responses to exercise in women using oral contraceptives. J Appl Physiol 70(5):1917–1927PubMed
Zurück zum Zitat Castracane VD, Kraemer RR, Franken MA, Kraemer GR, Gimpel T (1998) Serum leptin concentration in women: effect of age, obesity, and estrogen administration. Fertil Steril 70(3):472–477PubMedCrossRef Castracane VD, Kraemer RR, Franken MA, Kraemer GR, Gimpel T (1998) Serum leptin concentration in women: effect of age, obesity, and estrogen administration. Fertil Steril 70(3):472–477PubMedCrossRef
Zurück zum Zitat Coggan AR (1991) Plasma glucose metabolism during exercise in humans. Sports Med 11:102–104PubMedCrossRef Coggan AR (1991) Plasma glucose metabolism during exercise in humans. Sports Med 11:102–104PubMedCrossRef
Zurück zum Zitat Corr M, De Souza MJ, Toombs RJ, Williams NI (2011) Circulating leptin concentrations do not distinguish menstrual status in exercising women. Hum Reprod 26(3):685–694PubMedCrossRef Corr M, De Souza MJ, Toombs RJ, Williams NI (2011) Circulating leptin concentrations do not distinguish menstrual status in exercising women. Hum Reprod 26(3):685–694PubMedCrossRef
Zurück zum Zitat Devries MC, Hamadeh MJ, Phillips SM, Tarnopolsky MA (2006) Menstrual cycle phase and sex influence muscle glycogen utilization and glucose turnover during moderate-intensity endurance exercise. Am J Physiol Regul Integr Comp Physiol 291(4):R1120–R1128PubMedCrossRef Devries MC, Hamadeh MJ, Phillips SM, Tarnopolsky MA (2006) Menstrual cycle phase and sex influence muscle glycogen utilization and glucose turnover during moderate-intensity endurance exercise. Am J Physiol Regul Integr Comp Physiol 291(4):R1120–R1128PubMedCrossRef
Zurück zum Zitat Edelman SV, Caballero L (2006) Amylin replacement therapy in patients with type I diabetes. Diabetes Educ 32(suppl 3):119S–127SPubMedCrossRef Edelman SV, Caballero L (2006) Amylin replacement therapy in patients with type I diabetes. Diabetes Educ 32(suppl 3):119S–127SPubMedCrossRef
Zurück zum Zitat Höppener JW, Ahrén B, Lips CJ (2000) Islet amyloid and type 2 diabetes mellitus. N Engl J Med 343(6):411–419PubMedCrossRef Höppener JW, Ahrén B, Lips CJ (2000) Islet amyloid and type 2 diabetes mellitus. N Engl J Med 343(6):411–419PubMedCrossRef
Zurück zum Zitat Horton TJ, Miller EK, Glueck D, Tench K (2002) No effect of menstrual cycle phase on glucose kinetics and fuel oxidation during moderate-intensity exercise. Am J Physiol Endocrinol Metab 282(4):E752–E762PubMed Horton TJ, Miller EK, Glueck D, Tench K (2002) No effect of menstrual cycle phase on glucose kinetics and fuel oxidation during moderate-intensity exercise. Am J Physiol Endocrinol Metab 282(4):E752–E762PubMed
Zurück zum Zitat Isacco L, Duché P, Boisseau N (2012) Influence of hormonal status on substrate utilization at rest and during exercise in the female population. Sports Med 42(4):327–342PubMedCrossRef Isacco L, Duché P, Boisseau N (2012) Influence of hormonal status on substrate utilization at rest and during exercise in the female population. Sports Med 42(4):327–342PubMedCrossRef
Zurück zum Zitat Johnson LG, Kraemer RR, Haltom R, Kraemer GR, Gaines HE, Castracane VD (1997) Effects of estrogen replacement therapy on dehydroepiandrosterone, dehydroepiandrosterone sulfate, and cortisol responses to exercise in postmenopausal women. Fertil Steril 68(5):836–843PubMedCrossRef Johnson LG, Kraemer RR, Haltom R, Kraemer GR, Gaines HE, Castracane VD (1997) Effects of estrogen replacement therapy on dehydroepiandrosterone, dehydroepiandrosterone sulfate, and cortisol responses to exercise in postmenopausal women. Fertil Steril 68(5):836–843PubMedCrossRef
Zurück zum Zitat Johnson LG, Kraemer RR, Kraemer GR, Haltom RW, Cordill AE, Welsch MA, Durand RJ, Castracane VD (2002) Substrate utilization during exercise in postmenopausal women on hormone replacement therapy. Eur J Appl Physiol 88(3):282–287PubMedCrossRef Johnson LG, Kraemer RR, Kraemer GR, Haltom RW, Cordill AE, Welsch MA, Durand RJ, Castracane VD (2002) Substrate utilization during exercise in postmenopausal women on hormone replacement therapy. Eur J Appl Physiol 88(3):282–287PubMedCrossRef
Zurück zum Zitat Kraemer RR, Heleniak R, Tryniecki JL, Kraemer GR, Okazaki N, Castracane VD (1995) Follicular and luteal phase hormonal responses to low-volume resistive exercise in women. Med Sci Sports Exerc 27(60):809–817PubMed Kraemer RR, Heleniak R, Tryniecki JL, Kraemer GR, Okazaki N, Castracane VD (1995) Follicular and luteal phase hormonal responses to low-volume resistive exercise in women. Med Sci Sports Exerc 27(60):809–817PubMed
Zurück zum Zitat Kraemer RR, Johnson LG, Haltom RW, Kraemer GR, Gaines HE, Drapcho M, Castracane VD (1998) Effects of hormone replacement on growth hormone and prolactin exercise responses in postmenopausal women. J Appl Physiol 84(2):703–708PubMed Kraemer RR, Johnson LG, Haltom RW, Kraemer GR, Gaines HE, Drapcho M, Castracane VD (1998) Effects of hormone replacement on growth hormone and prolactin exercise responses in postmenopausal women. J Appl Physiol 84(2):703–708PubMed
Zurück zum Zitat Kraemer RR, Acevedo EO, Synovitz LB, Hebert EP, Gimpel T, Castracane VD (2001) Leptin and steroid hormone responses to exercise in adolescent female runners over a 7-week season. Eur J Appl Physiol 86(1):85–91PubMedCrossRef Kraemer RR, Acevedo EO, Synovitz LB, Hebert EP, Gimpel T, Castracane VD (2001) Leptin and steroid hormone responses to exercise in adolescent female runners over a 7-week season. Eur J Appl Physiol 86(1):85–91PubMedCrossRef
Zurück zum Zitat Kraemer RR, Acevedo EO, Synovitz LB, Durand RJ, Johnson LG, Petrella E, Fineman MS, Gimpel T, Castracane VD (2002) Glucoregulatory endocrine responses to intermittent exercise of different intensities: plasma changes in a pancreatic beta-cell peptide, amylin. Metabolism 51:657–663PubMedCrossRef Kraemer RR, Acevedo EO, Synovitz LB, Durand RJ, Johnson LG, Petrella E, Fineman MS, Gimpel T, Castracane VD (2002) Glucoregulatory endocrine responses to intermittent exercise of different intensities: plasma changes in a pancreatic beta-cell peptide, amylin. Metabolism 51:657–663PubMedCrossRef
Zurück zum Zitat Kraemer RR, Francois MR, Sehgal K, Sirikul B, Valverde RA, Castracane VD (2011) Amylin and selective glucoregulatory peptide alterations during prolonged exercise. Med Sci Sports Exerc 43(8):1451–1456PubMedCrossRef Kraemer RR, Francois MR, Sehgal K, Sirikul B, Valverde RA, Castracane VD (2011) Amylin and selective glucoregulatory peptide alterations during prolonged exercise. Med Sci Sports Exerc 43(8):1451–1456PubMedCrossRef
Zurück zum Zitat Kusakabe T, Ebihara K, Sakai T, Miyamoto L, Aotani D, Yamamoto Y, Yamamoto-Kataoka S, Aizawa-Abe M, Fujikura J, Hosoda K, Nakao K (2012) Amylin improves the effect of leptin on insulin sensitivity in leptin-resistant diet-induced obese mice. Am J Physiol Endocrinol Metab 302(8):E924–E931PubMedCrossRef Kusakabe T, Ebihara K, Sakai T, Miyamoto L, Aotani D, Yamamoto Y, Yamamoto-Kataoka S, Aizawa-Abe M, Fujikura J, Hosoda K, Nakao K (2012) Amylin improves the effect of leptin on insulin sensitivity in leptin-resistant diet-induced obese mice. Am J Physiol Endocrinol Metab 302(8):E924–E931PubMedCrossRef
Zurück zum Zitat Nadal A, Alonso-Magdalena P, Soriano S, Quesada I, Ropero AB (2009) The pancreatic beta-cell as a target of estrogens and xenoestrogens: implications for blood glucose homeostasis and diabetes. Mol Cell Endocrinol 304(1–2):63–68PubMedCrossRef Nadal A, Alonso-Magdalena P, Soriano S, Quesada I, Ropero AB (2009) The pancreatic beta-cell as a target of estrogens and xenoestrogens: implications for blood glucose homeostasis and diabetes. Mol Cell Endocrinol 304(1–2):63–68PubMedCrossRef
Zurück zum Zitat Nyholm B, Orskov L, Hove KY, Gravholt CH, Møller N, Alberti KG, Moyses C, Kolterman O, Schmitz O (1999) The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus. Metabolism 48:935–941PubMedCrossRef Nyholm B, Orskov L, Hove KY, Gravholt CH, Møller N, Alberti KG, Moyses C, Kolterman O, Schmitz O (1999) The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus. Metabolism 48:935–941PubMedCrossRef
Zurück zum Zitat Ojuka EO, Goyaram V, Smith JA (2012) The role of CaMKII in regulating GLUT4 expression in skeletal muscle. Am J Physiol Endocrinol Metab 303(3):E322–E331PubMedCrossRef Ojuka EO, Goyaram V, Smith JA (2012) The role of CaMKII in regulating GLUT4 expression in skeletal muscle. Am J Physiol Endocrinol Metab 303(3):E322–E331PubMedCrossRef
Zurück zum Zitat Polonsky K, Jaspan J, Pugh W, Cohen D, Schneider M, Schwartz T, Moossa AR, Tager H, Rubenstein AH (1983) Metabolism of C-peptide in the dog. In vivo demonstration of the absence of hepatic extraction. J Clin Invest 72:1114–1123PubMedCrossRef Polonsky K, Jaspan J, Pugh W, Cohen D, Schneider M, Schwartz T, Moossa AR, Tager H, Rubenstein AH (1983) Metabolism of C-peptide in the dog. In vivo demonstration of the absence of hepatic extraction. J Clin Invest 72:1114–1123PubMedCrossRef
Zurück zum Zitat Qi D, Cai K, Wang O, Li Z, Chen J, Deng B, Qian L, Le Y (2010) Fatty acids induce amylin expression and secretion by pancreatic beta-cells. Am J Physiol Endocrinol Metab 298(1):E99–E107PubMedCrossRef Qi D, Cai K, Wang O, Li Z, Chen J, Deng B, Qian L, Le Y (2010) Fatty acids induce amylin expression and secretion by pancreatic beta-cells. Am J Physiol Endocrinol Metab 298(1):E99–E107PubMedCrossRef
Zurück zum Zitat Schmitz O, Brock B, Rungby J (2004) Amylin agonists: a novel approach in the treatment of diabetes. Diabetes 53(suppl 3):S233–S238PubMedCrossRef Schmitz O, Brock B, Rungby J (2004) Amylin agonists: a novel approach in the treatment of diabetes. Diabetes 53(suppl 3):S233–S238PubMedCrossRef
Zurück zum Zitat Seufert J, Kieffer TJ, Habener JF (1999) Leptin inhibits insulin gene transcription and reverses hyperinsulinemia inleptin-deficient ob/ob mice. Proc Natl Acad Sci USA 19;96(2):674-679 Seufert J, Kieffer TJ, Habener JF (1999) Leptin inhibits insulin gene transcription and reverses hyperinsulinemia inleptin-deficient ob/ob mice. Proc Natl Acad Sci USA 19;96(2):674-679
Zurück zum Zitat Trevaskis JL, Lei C, Koda JE, Weyer C, Parkes DG, Roth JD (2010a) Interaction of leptin and amylin in the long-term maintenance of weight loss in diet-induced obese rats. Obesity (Silver Spring) 18(1):21–26CrossRef Trevaskis JL, Lei C, Koda JE, Weyer C, Parkes DG, Roth JD (2010a) Interaction of leptin and amylin in the long-term maintenance of weight loss in diet-induced obese rats. Obesity (Silver Spring) 18(1):21–26CrossRef
Zurück zum Zitat Trevaskis JL, Parkes DG, Roth JD (2010b) Insights into amylin-leptin synergy. Trends Endocrinol Metab 21(8):473–479PubMedCrossRef Trevaskis JL, Parkes DG, Roth JD (2010b) Insights into amylin-leptin synergy. Trends Endocrinol Metab 21(8):473–479PubMedCrossRef
Zurück zum Zitat Turcotte LP, Richter EA, Kiens B (1992)Increased plasma FFA uptake and oxidation during prolonged exercise in trained vs. untrained humans. Am J Physiol 262(6 Pt 1):E791–E799 Turcotte LP, Richter EA, Kiens B (1992)Increased plasma FFA uptake and oxidation during prolonged exercise in trained vs. untrained humans. Am J Physiol 262(6 Pt 1):E791–E799
Zurück zum Zitat Wahren J, Ekberg K, Johansson J, Henriksson M, Pramanik A, Johansson BL, Rigler R, Jörnvall H (2000) Role of C-peptide in human physiology. Am J Physiol Endocrinol Metab 278:E759–E768PubMed Wahren J, Ekberg K, Johansson J, Henriksson M, Pramanik A, Johansson BL, Rigler R, Jörnvall H (2000) Role of C-peptide in human physiology. Am J Physiol Endocrinol Metab 278:E759–E768PubMed
Zurück zum Zitat Wang M, Drucker DJ (1996) Activation of amylin gene transcription by LIM domain homeobox gene isl-1. Mol Endocrinol 10(3):243–251PubMedCrossRef Wang M, Drucker DJ (1996) Activation of amylin gene transcription by LIM domain homeobox gene isl-1. Mol Endocrinol 10(3):243–251PubMedCrossRef
Zurück zum Zitat Zderic TW, Coggan AR, Ruby BC (2001) Glucose kinetics and substrate oxidation during exercise in the follicular and luteal phases. J Appl Physiol 90(2):447–453PubMed Zderic TW, Coggan AR, Ruby BC (2001) Glucose kinetics and substrate oxidation during exercise in the follicular and luteal phases. J Appl Physiol 90(2):447–453PubMed
Metadaten
Titel
No effect of menstrual cycle phase on glucose and glucoregulatory endocrine responses to prolonged exercise
verfasst von
Robert R. Kraemer
Michelle Francois
Nancy Dardis Webb
Jennifer R. Worley
Sharon N. Rogers
Reid L. Norman
Urvi Shah
V. Daniel Castracane
Publikationsdatum
01.09.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Applied Physiology / Ausgabe 9/2013
Print ISSN: 1439-6319
Elektronische ISSN: 1439-6327
DOI
https://doi.org/10.1007/s00421-013-2677-9

Weitere Artikel der Ausgabe 9/2013

European Journal of Applied Physiology 9/2013 Zur Ausgabe

Neu im Fachgebiet Arbeitsmedizin

Das Geschlechterparadoxon in der gesundheitlich beeinträchtigten Lebenszeit – Ende eines Mythos?

Beginnend mit den 1920er-Jahren hat sich eine Vorstellung über die Geschlechterdifferenzen in Gesundheit und Mortalität etabliert, die von Lorber und Moore in dem einprägsamen Satz: „Women get sicker, but men die quicker“, zusammengefasst wurde [ 1 …, S. 13]. Tatsächlich erscheinen vor dem Hintergrund der höheren Lebenserwartung der Frauen die Studienergebnisse zu den Geschlechterdifferenzen in der Morbidität überraschend, wonach Frauen im Durchschnitt einen schlechteren Gesundheitszustand aufweisen als Männer [

Gesunde Lebenserwartung: Ein kritischer Blick auf Nutzen und Potenziale des demographischen Gesundheitsindikators

Open Access Leitthema

Die demographische Alterung hat vielfältige gesellschaftliche Konsequenzen, deren Ausmaß wesentlich vom Gesundheitszustand der Bevölkerung abhängt. Um diesen analysieren und bewerten zu können, wurden spezielle Kennziffern entwickelt, die in …

Wie hat sich die Lebenserwartung ohne funktionelle Einschränkungen in Deutschland entwickelt? Eine Analyse mit Daten des Deutschen Alterssurveys (DEAS)

Deutschland erfährt, wie andere Hocheinkommensstaaten, aufgrund kontinuierlich rückläufiger Mortalität und niedriger Geburtenraten tiefgreifende demografische Veränderungen. Der demografische Wandel führt in Deutschland zu einem zunehmend höheren …

Hitzeschutz im Fokus der hessischen Betreuungs- und Pflegeaufsicht

Open Access Klimawandel Übersichtsartikel

Im Sommer 2023 kündigte das Bundesministerium für Gesundheit (BMG) einen nationalen Hitzeschutzplan an und forderte die Länder auf, zu prüfen, „ob die Warnstufen des [Deutschen Wetterdienstes] DWD mit der Durchführung von Akutmaßnahmen …